Literature DB >> 2697686

Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1 beta.

S Sandler1, K Bendtzen, D L Eizirik, A Sjöholm, N Welsh.   

Abstract

Interleukin 1 (IL-1) has been suggested to cause the islet B cell destruction occurring during the development of insulin-dependent diabetes mellitus. One mechanism by which B cell loss can be compensated for is via de novo formation of new cells through replication. In the present study the replicatory activity of cells in isolated rat pancreatic islets and in the insulin-producing cell line RINm5F has been assessed by [3H]thymidine incorporation methods after exposure to 1-25 U/ml of human recombinant IL-1 beta (rIL-1 beta). In the rat islets [3H]thymidine incorporation was decreased by 20% 5 h after exposure to 25 U/ml rIL-1 beta. A similar inhibition was also observed in islets exposed to 2.5 and 12.5 U/ml rIL-1 beta. In the RINm5F cells there was a dose-dependent inhibition of the cell replication to approximately 50% of the controls in cells exposed to 25 U/ml rIL-1 beta for 48 h. This was also accompanied by an increased cell death, as measured by trypan blue inclusion (controls 13% and rIL-1 beta treated cells 25%). The insulin content of the RINm5F cells was reduced by about 40% after a 48-h exposure to 25 U/ml rIL-1 beta. When the exposure of the RINm5F cells to rIL-1 beta was decreased to 24 h there was no increased cell death, but a reduced replicatory activity was still observed. rIL-1 beta decreased the cellular content of the polyamines spermidine and spermine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697686     DOI: 10.1016/0165-2478(89)90164-8

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Interleukin-1 beta and GTP-binding proteins.

Authors:  A Sjöholm
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion.

Authors:  I C Green; C A Delaney; J M Cunningham; V Karmiris; C Southern
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

4.  An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta.

Authors:  D L Eizirik; D E Tracey; K Bendtzen; S Sandler
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

Review 5.  Role of Polyamines and Hypusine in β Cells and Diabetes Pathogenesis.

Authors:  Abhishek Kulkarni; Cara M Anderson; Raghavendra G Mirmira; Sarah A Tersey
Journal:  Metabolites       Date:  2022-04-12

Review 6.  Arginase 2 and Polyamines in Human Pancreatic Beta Cells: Possible Role in the Pathogenesis of Type 2 Diabetes.

Authors:  Lorella Marselli; Emanuele Bosi; Carmela De Luca; Silvia Del Guerra; Marta Tesi; Mara Suleiman; Piero Marchetti
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.